Published in World J Urol on January 01, 1994
Role of urothelial cells in BCG immunotherapy for superficial bladder cancer. Br J Cancer (2004) 1.04
Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy. Br J Cancer (2013) 0.82
Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes. World J Urol (2012) 0.81
Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol (1992) 6.13
Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J (1994) 5.70
The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol (1993) 4.18
Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol (1991) 3.82
First clinical experience with extracorporeally induced destruction of kidney stones by shock waves. J Urol (1982) 3.14
Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol (2001) 2.56
IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol (1989) 2.41
Discontinuous density gradient separation of human mononuclear leucocytes using Percoll as gradient medium. J Immunol Methods (1979) 2.17
Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol (2003) 2.14
New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest (1993) 2.10
Extracorporeal shock-wave lithotripsy (ESWL) for treatment of urolithiasis. Urology (1984) 2.08
Molecular mechanisms of endotoxin activity. Arch Microbiol (1995) 1.98
Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem (2000) 1.85
Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol (1996) 1.85
HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues. Pathol Res Pract (2001) 1.83
The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J (2003) 1.75
The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology (1993) 1.69
Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur J Immunol (2001) 1.68
Dynamic properties of water at phosphatidylcholine lipid-bilayer surfaces as seen by deuterium and pulsed field gradient proton NMR. Chem Phys Lipids (1994) 1.66
Inhibition of 3H-thymidine incorporation of lymphocytes by a soluble factor from macrophages. Cell Immunol (1975) 1.65
Optimizing syngeneic orthotopic murine bladder cancer (MB49). Cancer Res (1999) 1.61
Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun (1994) 1.59
Species-specific assessment of Mycobacterium leprae in skin biopsies by in situ hybridization and polymerase chain reaction. Lab Invest (1992) 1.55
Malignant extragastrointestinal stromal tumor of bladder. J Urol (2003) 1.55
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood (2000) 1.52
Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways. Discrepancies in binding affinities, receptor densities, and biologic effects. J Immunol (1994) 1.52
The role of tumor necrosis factor in the development of multiple organ failure in a murine model. Crit Care Med (2000) 1.51
Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology (1988) 1.51
Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol (1993) 1.49
EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol (2004) 1.47
Biochemical characterization of a factor released by macrophages. Cell Immunol (1975) 1.44
The quality of life during intravesical bacillus Calmette-Guerin therapy. J Urol (1996) 1.43
Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol (1994) 1.43
Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun (1997) 1.40
Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes. Infect Immun (1994) 1.39
Induction of human interleukin 1 by bacterial and synthetic lipid A. Eur J Immunol (1986) 1.36
Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J Immunol (1998) 1.34
Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. Am J Respir Crit Care Med (1996) 1.33
Characterisation of guinea pig precision-cut lung slices: comparison with human tissues. Eur Respir J (2006) 1.32
Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol (1999) 1.31
Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation (1997) 1.31
The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J Leukoc Biol (2000) 1.31
In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol (1990) 1.31
Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component. Infect Immun (2000) 1.27
The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J Immunol (1998) 1.27
Isolation and subfractionation of human peripheral blood mononuclear cells (PBMC) by density gradient centrifugation on Percoll. Immunobiology (1984) 1.26
Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes. Scand J Immunol (1991) 1.26
Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy. Am J Pathol (1990) 1.25
Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria. Infect Immun (1996) 1.25
Assessment of transcriptional gene activity in situ by application of HOPE-fixed, paraffin-embedded tissues. Pathol Res Pract (2002) 1.25
IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol (1995) 1.23
Platelet-derived CXC chemokines: old players in new games. Immunol Rev (2000) 1.21
Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy. J Urol (1990) 1.20
Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures. Infect Immun (1992) 1.20
Interleukin-1 gene expression in rabbit vascular tissue in vivo. Am J Pathol (1991) 1.19
Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Lett (1996) 1.19
Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. J Urol (1990) 1.19
Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation (1993) 1.19
NK cells are essential for effective BCG immunotherapy. Int J Cancer (2001) 1.19
Epitope analysis of antibodies recognising the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein). J Clin Pathol (1994) 1.18
Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem (1997) 1.17
CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7. Scand J Immunol (1990) 1.16
Inhibition of HIV progression by dithiocarb. German DTC Study Group. Lancet (1990) 1.15
IPSE/alpha-1: a major immunogenic component secreted from Schistosoma mansoni eggs. Mol Biochem Parasitol (2006) 1.15
Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J Immunol (2001) 1.15
Treatment of posttransplant hypertension by laparoscopic bilateral nephrectomy? Transplantation (1998) 1.14
Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol Med Microbiol (1996) 1.13
Interactions of CD14 with components of gram-positive bacteria. Chem Immunol (2000) 1.13
Effect of in vitro infection of human monocytes with low numbers of Mycobacterium tuberculosis bacteria on monocyte apoptosis. Infect Immun (1996) 1.13
Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes. J Immunol (1994) 1.13
Induction of tumor necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures. Immunobiology (1989) 1.12
Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation (1998) 1.11
IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer. Clin Exp Immunol (2002) 1.11
The early allergic response in small airways of human precision-cut lung slices. Eur Respir J (2003) 1.11
Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood (1998) 1.10